Pfizer stock drops after slump in Celebrex prescriptions
561772
NEW YORK  - Drugs giant Pfizer Inc.&#39;s stock fell on a report that new prescriptions for its blockbuster pain medication Celebrex slumped 56 percent last week.
12579
Pfizer saw a 13 percent decline in sales of its best-selling cholesterol treatment, Lipitor, which contributed to lower-than-expected second quarter earnings.
194747
Shares in Pfizer Inc  fell around 14 percent in European and pre-opening U.S. trade on Monday after the world's biggest drugmaker scrapped development of its most important experimental medicine.
489823
Shares in Pfizer Inc, the world's biggest drugmaker, fell more than 10 percent in early trade in Europe on Monday, after news it had scrapped its most important experimental drug.
632199
Pfizer Inc.&#39;s shares fell as much as 6.2 percent on Thursday on a Canadian newspaper report linking its arthritis drug Celebrex to 14 deaths.
132494
US stocks fell as setbacks for drugmakers, including a study showing Pfizer Inc.&#39;s Celebrex painkiller increased the risk of heart attacks, sent health-care shares tumbling.
748158
U.S. stocks slipped on Thursday,  pulled down by investor worries over record high oil prices and  a sharp drop in major drug company shares.
698753
MedImmune Inc.&#39;s cancellation of trials for an arthritis and psoriasis treatment sent the company&#39;s stock lower Monday and helped drag down the entire biotechnology sector.
238512
Shares of Pfizer Inc., the world's largest drugmaker, sank Monday on news that the company had halted development of a key new cholesterol treatment that was heralded as its engine for future growth as the company struggles with stagnant sales.
204220
Pfizer Inc.'s decision to scrap development of a crucial medicine sent its shares plummeting yesterday as analysts fretted about its future and speculated about which companies it might purchase to shore up its pipeline.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
564654
Drugmaker Pfizer Inc. said Wednesday its second-quarter profit fell 48 percent year-over-year, hurt by the loss of patent exclusivity for its Zoloft and Norvasc drugs and by sluggish sales of blockbuster cholesterol drug, Lipitor, in the U.S.
505706
Global drugs giant Pfizer sees profits fall after a drop in worldwide sales of cholesterol drug Lipitor.
333055
New prescriptions for Pfizer Inc.'s  arthritis drug Celebrex fell 56 percent last week after the  company released data showing the drug may increase the risk of  heart attacks and strokes, according to Verispan, a market  research company.
509694
Pfizer Inc.  on Wednesday  reported lower-than-expected quarterly earnings on competition  with generics, and said global sales of cholesterol fighter  Lipitor fell 13 percent amid slipping demand for the company&#39;s  flagship product.
101354
A day after Whitehouse Station-based Merck abruptly withdrew from the market Vioxx, its blockbuster arthritis drug, Pfizer yesterday moved to promote Celebrex, its competing medicine.
599967
New prescriptions for Pfizer Inc.'s  arthritis drug Celebrex fell 56 percent last week after the  company released data showing the drug may increase the risk of  heart attacks and strokes, the Wall Street Journal said.